Effect of in Vivo Administration of Anti-Ctla-4 Monoclonal Antibody and IL-12 on the Induction of Low-Dose Oral Tolerance

Clinical and Experimental Immunology - United Kingdom
doi 10.1046/j.0009-9104.2002.01961.x
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Wiley

Related search

Dose-Dependent Effect of Anti-Ctla-4 on Survival in Sepsis

Shock
Critical CareEmergency MedicineIntensive Care Medicine
2011English

Enhancement of Oncolytic Activity of oHSV Expressing IL-12 and Anti PD-1 Antibody by Concurrent Administration of Exosomes Carrying CTLA-4 miRNA

2019English

Anti-Il-20 Monoclonal Antibody Alleviates Inflammation in Oral Cancer and Suppresses Tumor Growth

Molecular Cancer Research
Cancer ResearchOncologyMolecular Biology
2012English

Human Monoclonal Anti-Protective Antigen Antibody for the Low-Dose Post-Exposure Prophylaxis and Treatment of Anthrax

BMC Infectious Diseases
Infectious Diseases
2018English

Ipilimumab: An Anti-Ctla-4 Antibody for Metastatic Melanoma

Clinical Cancer Research
Cancer ResearchOncology
2011English

Pharmacokinetics of Tildrakizumab (MK-3222), an Anti-Il-23 Monoclonal Antibody, Following Intravenous or Subcutaneous Administration in Healthy Subjects

Basic and Clinical Pharmacology and Toxicology
MedicineToxicologyPharmacology
2018English

Therapeutic Effect of Anti-Nucleokine Monoclonal Antibody on Ischemic Brain Infarction

Yakugaku Zasshi
PharmacologyPharmaceutical Science
2009English

Treatment of Atopic Dermatitis With Tralokinumab, an Anti–IL-13 Monoclonal Antibody

Journal of Allergy and Clinical Immunology
AllergyImmunology
2019English

Syngeneic Animal Models of Tobacco-Associated Oral Cancer Reveal the Activity of in Situ Anti-Ctla-4

Nature Communications
AstronomyGeneticsMolecular BiologyBiochemistryChemistryPhysics
2019English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2025 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy